Business Context and Reporting Period
This Form 8-K Current Report was filed by AmerisourceBergen Corporation (now Cencora, Inc.) on May 13, 2013. The report details the completion of a strategic divestiture of the Company's contract packaging business, AndersonBrecon Inc. and AndersonBrecon (UK) Limited.
Key Financial Metrics
- Transaction Value: The divestiture was completed for a purchase price of $308 million in cash, subject to customary working capital adjustments.
- Accounting Treatment: The results of operations for AndersonBrecon are reported within discontinued operations.
- Impact on Core Metrics: The filing states that the completion of this divestiture has no impact on the Company's financial performance expectations for fiscal 2013.
- Gain Recognition: Any gain on the sale will be recorded within discontinued operations and is excluded from fiscal 2013 financial expectations.
Material Changes
The primary material change is the exit from the contract packaging business segment. The buyer is an entity formed by affiliates of an investor group led by Frazier Healthcare VI, L.P., which also includes affiliates of Greenspring Associates, QIC Global Private Equity, and Thomas McNerney & Partners.
Guidance, Outlook, and Management Commentary
Management confirmed that the Company's financial performance expectations for fiscal 2013, previously updated in a Form 8-K filed on April 25, 2013, remain unchanged by this transaction. The filing explicitly notes that the gain from the sale is excluded from these expectations.
Investor Verification Checklist
- Verify the final purchase price after customary working capital adjustments.
- Review the April 25, 2013 Form 8-K to confirm the specific fiscal 2013 financial expectations referenced.
- Confirm the classification of AndersonBrecon results as discontinued operations in subsequent quarterly filings.
- Monitor the timing of the cash receipt and any associated tax implications of the gain.